Aspen Pharmacare | APN - Gross Profit On Sales

Stock Price
13,541.00
Daily Change
-11.00 -0.08%
Monthly
22.38%
Yearly
-17.08%
Q1 Forecast
12,238.27

Aspen Pharmacare reported ZAR10.14B in Gross Profit on Sales for its fiscal semester ending in June of 2024.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 41.64B 6.31B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Jiangsu Hengrui CNY 6.36B 1.15B Sep/2025
Kalbe Farma IDR 3.45T 151.13B Sep/2025
Life Healthcare ZAR 14.66B 1.12B Dec/2022
Netcare ZAR 5.51B 475M Dec/2022
Richter Gedeon HUF 143.37B 4.3B Sep/2025